PDS Bio is the new #1

NEW #1:  PDS Bio unseats Novavax at the top!

An incredible unstoppable run by PDS Bio, this week with a 320% gain in overall return, puts it in the #1 spot. Novavax, with a 29% overall gain falls to second. PDS Bio has now returned 908% since the beginning of the pandemic, while Novavax has returned 823%. 

For the week, the average overall return for all 27 COVID VACCINE STOCKS climbed up from 168% to 183%. Much of that gain coming from PDS.

 

Flat day prior to Memorial Day - PDS Bio #1 again today

A promising day turned flat with the late afternoon, pre-holiday weekend sell-off. The result was 13 gainers and 13 losers. The overall average was a gain of 0.6%.

The current champion, PDSB, was the #1 stock again, picking up just over 5.5%. Lowly Emergent Bio picked up 5% on some positive non-Covid clinical data.

The weakest stock was iBio falling just over 3%.

 

PDS Bio still on fire - gaining another 19% today on strong day

Strong up day, lead by PDS Bio again - this time it had a 19% gain. This is the hottest COVID VACCINE STOCK by far. 

The overall average was a gain of 2.5% with 22 winners and 4 losers.

Other winners include: iBio, Altimmune and VBIV with gains of 7%. Vaxart, Inovio and Immunity Bio all had gains of 5%. 

Relatively flat day - Big companies gain and smaller companies lose.

No stocks moved more than 5% for first time ever. Big companies, with Market Value of over $5B all gained, while those below with the exception of NanoViricides and GeoVax, all lost.

Seventeen stocks lost ground and 10 gained. The overall average was a lost of 0.5%.

iBio was the biggest loser, falling 4%, While Vir and Moderna gained 3%.

 

Altimmune craters 14% on relatively flat day.

Relatively calm day with 17 stocks losing ground and 10 gaining ground. Altimmune suffered an out-sized loss, falling 14%, notwithstanding that readings on the COVID vaccine and cancer vaccine is pending next month. The overall average was a loss of 1.3%.

Vaxart and GeoVax suffered 5% losses. 

On the upside, the unstoppable PDS gained 5%.

 

Tonix moves up in BOTTOM TEN

Tonix edges higher with a 9% gaining week. Emergent and Vir slip 6%.

 

PDS bio's time to shine - rockets to 2nd in positive week.

PDS Bio is the story this week. From a very strong Top 4 performer with a return of 293%, it hit the stratosphere this week with a gain of 295% total return to settle in second overall at 588%. It literally blew by Moderna and BioNTech. It is not just 206% behind the pacesetter, Novavax.

A positive week, moved these stocks from the depths of just an average overall return of 143% up to 168% for a gain of 25% return.